Status:
UNKNOWN
Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients
Lead Sponsor:
Sohag University
Conditions:
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
In this study, measurements of central macular thickness using optical coherence tomography along with examination of visual acuity by Snellen's chart in diabetic hypertensive patients will be done .
Detailed Description
correlate relationship between optical coherence tomography changes and visual acuity in patients with type 2 diabetes and hypertension
Eligibility Criteria
Inclusion
- Type 2 diabetic patients with hypertension .
Exclusion
- Patients with type 1 diabetes mellitus .
- Ocular disease ( such as high myopia , glaucoma ) .
- Patients with opacities in the media ( corneal opacities , dense cataract , vitreous hemorrhage ) .
- Systemic medication (Tamoxifen , Chloroquine , Canthaxanthine ) to avoid its effect on macular thickness .
- Central visual field defect that prevents fixation on OCT .
- Intraocular inflammation such as anterior or posterior uveitis .
- Refractive error greater than 6 diopter .
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05209971
Start Date
January 1 2022
End Date
December 1 2022
Last Update
January 27 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.